These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20589920)

  • 1. Effect of nicotine on saccadic eye movement latencies in non-smokers.
    Bowling AC; Donnelly JF
    Hum Psychopharmacol; 2010 Jul; 25(5):410-8. PubMed ID: 20589920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine improves antisaccade task performance without affecting prosaccades.
    Larrison AL; Briand KA; Sereno AB
    Hum Psychopharmacol; 2004 Aug; 19(6):409-19. PubMed ID: 15303245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine reduces antisaccade errors in task impaired schizophrenic subjects.
    Larrison-Faucher AL; Matorin AA; Sereno AB
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):505-16. PubMed ID: 15093958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERP indices of persisting and current inhibitory control: a study of saccadic task switching.
    Mueller SC; Swainson R; Jackson GM
    Neuroimage; 2009 Mar; 45(1):191-7. PubMed ID: 19100841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease?
    van Stockum S; MacAskill M; Anderson T; Dalrymple-Alford J
    Neuropsychologia; 2008 Nov; 46(13):3108-15. PubMed ID: 18674551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed pro and antisaccade performance in children and adults.
    Irving EL; Tajik-Parvinchi DJ; Lillakas L; González EG; Steinbach MJ
    Brain Res; 2009 Feb; 1255():67-74. PubMed ID: 19103183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of prosaccade and antisaccade task performance in participants aged 6 to 26 years.
    Klein C; Foerster F
    Psychophysiology; 2001 Mar; 38(2):179-89. PubMed ID: 11347863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls.
    Petrovsky N; Ettinger U; Quednow BB; Landsberg MW; Drees J; Lennertz L; Frommann I; Heilmann K; Sträter B; Kessler H; Dahmen N; Mössner R; Maier W; Wagner M
    Int J Neuropsychopharmacol; 2013 Aug; 16(7):1473-81. PubMed ID: 23399382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antisaccade task as an index of sustained goal activation in working memory: modulation by nicotine.
    Rycroft N; Hutton SB; Rusted JM
    Psychopharmacology (Berl); 2006 Nov; 188(4):521-9. PubMed ID: 16896958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancelling of pursuit and saccadic eye movements in humans and monkeys.
    Kornylo K; Dill N; Saenz M; Krauzlis RJ
    J Neurophysiol; 2003 Jun; 89(6):2984-99. PubMed ID: 12783947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.
    Poltavski DV; Petros T
    Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicotine on response inhibition and interference control.
    Ettinger U; Faiola E; Kasparbauer AM; Petrovsky N; Chan RC; Liepelt R; Kumari V
    Psychopharmacology (Berl); 2017 Apr; 234(7):1093-1111. PubMed ID: 28150023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.
    Potter AS; Newhouse PA
    Pharmacol Biochem Behav; 2008 Feb; 88(4):407-17. PubMed ID: 18022679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered control of visual fixation and saccadic eye movements in attention-deficit hyperactivity disorder.
    Munoz DP; Armstrong IT; Hampton KA; Moore KD
    J Neurophysiol; 2003 Jul; 90(1):503-14. PubMed ID: 12672781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic interaction between "Go" and "Stop" signals in the saccadic eye movement system: New evidence against the functional independence of the underlying neural mechanisms.
    Montagnini A; Chelazzi L
    Vision Res; 2009 Jun; 49(10):1316-28. PubMed ID: 18713642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor antisaccade performance in schizophrenia: an inhibition deficit?
    Reuter B; Rakusan L; Kathmanna N
    Psychiatry Res; 2005 May; 135(1):1-10. PubMed ID: 15893384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural processes associated with antisaccade task performance investigated with event-related FMRI.
    Ford KA; Goltz HC; Brown MR; Everling S
    J Neurophysiol; 2005 Jul; 94(1):429-40. PubMed ID: 15728770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory control of saccadic eye movements and cognitive impairment in Alzheimer's disease.
    Crawford TJ; Higham S; Renvoize T; Patel J; Dale M; Suriya A; Tetley S
    Biol Psychiatry; 2005 May; 57(9):1052-60. PubMed ID: 15860346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison.
    Rycroft N; Hutton SB; Clowry O; Groomsbridge C; Sierakowski A; Rusted JM
    Psychopharmacology (Berl); 2007 Dec; 195(2):245-53. PubMed ID: 17676402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute nicotine on brain function in healthy smokers and non-smokers: estimation of inter-individual response heterogeneity.
    Ettinger U; Williams SC; Patel D; Michel TM; Nwaigwe A; Caceres A; Mehta MA; Anilkumar AP; Kumari V
    Neuroimage; 2009 Apr; 45(2):549-61. PubMed ID: 19159693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.